申请人:Medshine Discovery Inc.
公开号:EP3919492A1
公开(公告)日:2021-12-08
Disclosed are a pyrimidinyl group-containing tricyclic compound and applications thereof in preparing a cancer-treating medicament. Specifically disclosed are a compound as represented by formula (I), a pharmaceutically acceptable salt of same, or an isomer thereof.
本发明公开了一种含嘧啶基团的三环化合物及其在制备癌症治疗药物中的应用。具体公开了式 (I) 所代表的化合物、其药学上可接受的盐或其异构体。